Medicare Enrolled

Dr. Jonathan Galli, M.D.

Pulmonary Disease · Marlton, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
141 ROUTE 70 E STE B, Marlton, NJ 08053
8565969057
In practice since 2011 (15 years)
NPI: 1306139159 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Galli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Galli? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Galli

Dr. Jonathan Galli is a pulmonary disease specialist in Marlton, NJ, with 15 years of NPI registration. Based on federal Medicare data, Dr. Galli performed 1,870 Medicare services across 1,404 unique beneficiaries.

Between the years covered by Open Payments, Dr. Galli received a total of $3,430 from 21 pharmaceutical and/or device companies across 83 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Galli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 36% volume in NJ $3,430 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,870
Medicare services
Top 36% in NJ for pulmonary disease
1,404
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~125 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
549 $65 $164
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
247 $145 $430
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
219 $105 $284
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
205 $99 $240
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
188 $180 $596
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
94 $132 $365
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
82 $46 $185
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
45 $30 $200
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
45 $38 $145
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
41 $29 $110
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
40 $23 $120
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
39 $44 $180
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
25 $102 $291
Chest fluid aspiration with imaging guidance
This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement.
21 $92 $363
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
16 $135 $395
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
14 $73 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,430
Total received (2019-2024)
Avg $857/year across 4 years
Top 40% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
83
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,887 (55.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,443 (42.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,090
2023
$213
2021
$27
2019
$100

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$1,887
GlaxoSmithKline, LLC.
$384
AstraZeneca Pharmaceuticals LP
$177
Regeneron Healthcare Solutions, Inc.
$176
Actelion Pharmaceuticals US, Inc.
$63
Philips North America LLC
$60
Genentech USA, Inc.
$51
HARMONY BIOSCIENCES LLC
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
JAZZ PHARMACEUTICALS INC.
$36
Bayer Healthcare Pharmaceuticals Inc.
$36
Amgen Inc.
$32
Insmed, Inc.
$19
3B Medical, Inc.
$18
Avadel CNS Pharmaceuticals, LLC
$17
Mylan Specialty L.P.
$16
Inspire Medical Systems, Inc.
$15
Breas Medical, Inc.
$15
United Therapeutics Corporation
$14
Top 3 companies account for 79.2% of 2024 payments
All-time payments by company (2019-2024) ›
GENZYME CORPORATION
$1,907
GlaxoSmithKline, LLC.
$449
AstraZeneca Pharmaceuticals LP
$223
Regeneron Healthcare Solutions, Inc.
$176
Genentech USA, Inc.
$151
Actelion Pharmaceuticals US, Inc.
$90
Philips North America LLC
$60
JAZZ PHARMACEUTICALS INC.
$52
HARMONY BIOSCIENCES LLC
$37
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
Bayer Healthcare Pharmaceuticals Inc.
$36
United Therapeutics Corporation
$32
Amgen Inc.
$32
Harmony Biosciences LLC
$32
Insmed, Inc.
$19
3B Medical, Inc.
$18
Avadel CNS Pharmaceuticals, LLC
$17
Pharming Healthcare, Inc.
$17
Mylan Specialty L.P.
$16
Inspire Medical Systems, Inc.
$15
Breas Medical, Inc.
$15
Top 3 companies account for 75.2% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · AIRSUPRA · AREXVY · Adempas · Arikayce · DUPIXENT · Esbriet · FASENRA · INSPIRE · LUMRYZ · LUNA · NUCALA · OFEV · OPSUMIT · RUCONEST · SPIRIVA RESPIMAT · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · UPTRAVI · Vivo 45 LS · WAKIX · XYWAV · Xolair · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a pulmonary disease specialist in Marlton?
Compare pulmonary diseases in the Marlton area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
241
Per 100K population
51.9
County median income
$105,271
Nearest hospital
WEISMAN CHILDRENS REHABILITATION HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Galli is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Galli experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Galli performed 549 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Galli receive payments from pharmaceutical companies?
Yes. Dr. Galli received a total of $3,430 from 21 companies across 83 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Galli's costs compare to other pulmonary diseases in Marlton?
Dr. Galli's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Galli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →